12,000
Participants
Start Date
May 15, 2025
Primary Completion Date
December 31, 2035
Study Completion Date
December 31, 2035
Patients treated with NeuroStar TMS
non-invasive brain stimulation device
Patients treated with Esketamine
nasal spray for treating depression
RECRUITING
Neuronetics, Malvern
Lead Sponsor
Neuronetics
OTHER